Invesco Ltd. Nurix Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 413,340 shares of NRIX stock, worth $8.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

413,340

Previous 365,298 13.15%

Holding current value

$8.2 Million

Previous $7.62 Million 21.72%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.93 - $25.69 $909,435 - $1.23 Million	48,042 Added 13.15%	413,340 $9.28 Million
Q2 2024 Aug 13, 2024	BUY	$12.02 - $21.3 $629,703 - $1.12 Million	52,388 Added 16.74%	365,298 $7.62 Million
Q1 2024 May 14, 2024	BUY	$7.77 - $15.66 $2.04 Million - $4.1 Million	262,085 Added 515.66%	312,910 $4.6 Million
Q4 2023 Feb 12, 2024	BUY	$4.25 - $10.71 $14,539 - $36,638	3,421 Added 7.22%	50,825 $524,000
Q3 2023 Nov 13, 2023	SELL	$7.86 - $10.08 $2,578 - $3,306	-328 Reduced 0.69%	47,404 $372,000
Q2 2023 Aug 11, 2023	SELL	$8.7 - $13.28 $6,107 - $9,322	-702 Reduced 1.45%	47,732 $476,000
Q1 2023 May 12, 2023	BUY	$8.56 - $13.26 $284,072 - $440,046	33,186 Added 217.64%	48,434 $430,000
Q4 2022 Feb 13, 2023	SELL	$9.86 - $14.59 $295 - $437	-30 Reduced 0.2%	15,248 $167,000
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $24,425 - $39,243	1,981 Added 14.9%	15,278 $199,000
Q2 2022 Aug 15, 2022	SELL	$7.88 - $14.82 $409 - $770	-52 Reduced 0.39%	13,297 $168,000
Q1 2022 May 16, 2022	BUY	$12.94 - $29.65 $2,303 - $5,277	178 Added 1.35%	13,349 $187,000
Q4 2021 Feb 14, 2022	SELL	$26.43 - $34.5 $75,404 - $98,428	-2,853 Reduced 17.8%	13,171 $382,000
Q3 2021 Nov 15, 2021	BUY	$22.71 - $36.69 $57,683 - $93,192	2,540 Added 18.84%	16,024 $480,000
Q2 2021 Aug 17, 2021	BUY	$24.21 - $35.89 $326,447 - $483,940	13,484 New	13,484 $358,000

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account